EFFECT OF ORGANIC GERMANIUM COMPOUND (GE-132) ON EXPERIMENTAL OSTEOPOROSIS IN RATS

Citation
A. Fujii et al., EFFECT OF ORGANIC GERMANIUM COMPOUND (GE-132) ON EXPERIMENTAL OSTEOPOROSIS IN RATS, General pharmacology, 24(6), 1993, pp. 1527-1532
Citations number
21
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
03063623
Volume
24
Issue
6
Year of publication
1993
Pages
1527 - 1532
Database
ISI
SICI code
0306-3623(1993)24:6<1527:EOOGC(>2.0.ZU;2-J
Abstract
1. The therapeutic effect of organic germanium compound, 2-carboxyethy lgermanium-sesquioxide (Ge-132), for experimental osteoporosis was stu died using ovariectomized rats maintained on a low calcium containing diet. 2. Serum calcitonin (sCT) level was decreased and serum parathyr oid hormone (sPTH) level was increased by ovariectomy and the decremen t and increment rates, respectively, were reduced by administration of Ge-132. Thus, the sCT/sPTH ratio was greater in the groups given Ge-1 32, indicating that the resorption was somehow inhibited by Ge-132. 3. The transverse strength of femur bone was significantly enhanced by G e-132.4. A trend was found in the group given Ge-132 for a larger femu r cortical bone index. 5. The relative femur bone wet weight was great er in the group given Ge-132. 6. These results indicate that Ge-132 pr events decreased bone strength, and affects the femur cortical bone in dex, and bone mineral mass caused by osteoporosis.